project id: TCGA-OV; case submitter id: TCGA-04-1361; selected normal wxs: true; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.0; spectrophotometer method: UV Spec; age at index: 57; days to birth: -20860; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 20860; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 989.0; figo stage: Stage IIIB; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; preservation method: Unknown; specimen type: Solid Tissue; sample id: 702cc8d9-38f6-474a-bd7e-e56820c5a5b0; sample submitter id: TCGA-04-1361-01A; portion id: 649a4231-7a0f-4457-923c-58b9eedfe777; portion submitter id: TCGA-04-1361-01A-01; percent necrosis: 1.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 69.0; percent tumor nuclei: 80.0;